A Phase I, Randomized, Single-Dose Study to Evaluate the Biosimilarity of QL1206 to Denosumab Among Chinese Healthy Subjects

OBJECTIVE: This study was conducted to explore the tolerance, variability, pharmacokinetics (PK), and pharmacodynamics (PD) of denosumab biosimilar (QL1206) in healthy Chinese subjects. METHODS: This is a randomized, double-blind, two-arm, parallel study performed to examine the bioequivalence of de...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hong, Wu, Min, Zhu, Xiaoxue, Li, Cuiyun, Li, Xiaojiao, Sun, Jixuan, Liu, Chengjiao, Liu, Quan, Wei, Wei, Niu, Junqi, Ding, Yanhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580200/
https://www.ncbi.nlm.nih.gov/pubmed/33132906
http://dx.doi.org/10.3389/fphar.2020.01329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580200/
https://www.ncbi.nlm.nih.gov/pubmed/33132906
http://dx.doi.org/10.3389/fphar.2020.01329

Ejemplares similares